Emergent BioSolutions, Inc. (CBN)
1Q 2012 Earnings Call
May 3, 2012 17:00 p.m. ET
Bob Burrows – Vice President IR
Dan Abdun-Nabi – President and CEO
Don Elsey – Senior Vice President Finance and Administration, CFO
W. James Jackson, Ph.D. – Senior Vice President, CSO
Adnan Butt – RBC Capital Markets
Corey Kasimov – JP Morgan
Ian Somaiya - Piper Jaffray
Nicholas Bishop - Cowen and Company
Jim Molloy - ThinkEquity
Good day, ladies and gentlemen and welcome to the first quarter 2012 Emergent BioSolutions Incorporated Earnings Conference Call. My name is Jeff and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. Later we will facilitate a question-and-answer session. (Operator Instructions) As a reminder, this conference is being recorded for replay purposes.
I would now like to turn the conference over to your host for today, Mr. Bob Burrows, Vice President of Investor Relations. You have the floor, sir.
Thank you, Jeff. Good afternoon, ladies and gentlemen. Thank you for joining us today as we discuss Emergent BioSolutions first quarter 2012 financial results. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions.
Joining me on the call this afternoon with prepared comments will be Dan Abdun-Nabi, our President and Chief Executive Officer and Don Elsey, our Chief Financial Officer. Additional members of our senior management will be present on the call for purposes of the Q&A session.